U.S. Approves Skin Cancer Treatment

Related Link: 

The FDA granted accelerated approval to Bristol-Myers’s skin-cancer treatment Opdivo, which uses the body’s immune system to fight tumors.

Brazil's Rousseff Has No Plans to Change Management at Petrobras

Related Link: 

Brazilian President Dilma Rousseff said Monday she has no plans to make changes among the management at scandal-plagued state-controlled oil company Patroleo Brasileiro SA, or Petrobras.

FTC Puts Conditions on Lilly's Deal to Buy Novartis Unit

Related Link: 

The Federal Trade Commission said it put conditions on Eli Lilly and Co.’s proposed deal to buy Switzerland-based Novartis AG’s Animal Health division.

Monday's Deluge to Test UPS's New System

Related Link: 

UPS all year has been focused on one day above the rest: Monday Dec. 22, when it will deliver 34 million packages, more than any other in its history—putting a new high-tech sorting system to the test.

Trump Taj Mahal to Stay Open Into New Year, Lawyer Says

Related Link: 

The Trump Taj Mahal will remain in operation through Christmas and into the New Year, due to a $20 million loan from secured lender Carl Icahn, a lawyer for the casino operator said Monday.

Thaw Boosts Cuba-Asset Claims

Related Link: 

Now that the U.S. is moving to normalize relations with Cuba, the countries will have to deal with claims, valued at over $7 billion, from firms whose property was nationalized.

Ferrovial Drops Transfield Bid

Related Link: 

Ferrovial abandoned a takeover bid for Australia’s Transfield Services, a major setback in the Spanish construction company’s plan to compete for billions of dollars of new infrastructure projects Down Under.

Court Denies Family Dollar Shareholder Move

Related Link: 

A Delaware court has denied a motion brought by Family Dollar Stores Inc. shareholders to block Tuesday’s vote on the company’s proposed tie-up with Dollar Tree Inc.--a move intended to push the company to negotiate with rival Dollar General Corp.

FDA Oversight in the Internet Age

Related Link: 

An FDA rebuke of televised comments made by Aegerion’s CEO—which led the company to air a TV commercial correcting the statements—was prompted by complaints from a government drug reviewer, according to emails viewed by The Wall Street Journal.

Achillion Says Hepatitis Studies Show Strong Results

Related Link: 

Achillion Pharmaceuticals said that a regimen intended to treat hepatitis C patients showed strong results amid an increasingly competitive market for drugs to fight the disease

Syndicate content